Market Place
Sourcing Support
Aspargo Labs Reports Faster Absorption Of Oral ED Spray Vs. Viagra®
30 Jul 2024 //
BUSINESSWIRE
Aspargo Announces Completion of Dosing of All Subjects in Sildenafil Study
05 Dec 2023 //
GLOBENEWSWIRE
Aspargo Announces Initial Dosing of All Subjects in Bioavailability Study
19 Sep 2023 //
GLOBENEWSWIRE
Aspargo Laboratories Announces IND Clearance, Enabling Launch of Bioequivalence
05 Sep 2023 //
GLOBENEWSWIRE
Aspargo Announces Filing of Its Investigational NDA for Sildenafil Oral Spray
01 Aug 2023 //
GLOBENEWSWIRE
Aspargo Receives Regulatory Approval to Market Sildenafil Spray in Germany
24 Jan 2023 //
GLOBENEWSWIRE
Aspargo Extends Latin America Reach From Mexico to Argentina
29 Nov 2022 //
GLOBENEWSWIRE
Aspargo’s Global Footprint Grows With Middle East Expansion
04 Oct 2022 //
GLOBENEWSWIRE
Aspargo Expands Beyond Spain Into Latin America, Disrupting ED Market
21 Jun 2022 //
GLOBENEWSWIRE
Aspargo Acquires Bandol Sildenafil Spray, Currently Marketed In Spain
04 May 2022 //
GLOBENEWSWIRE
Aspargo Laboratories Acquires International Rights to Sildenafil Oral Spray
29 Sep 2020 //
GLOBENEWSWIRE
Aspargo Laboratories Completes Pre-IND Meeting with FDA
10 Jun 2020 //
CONTRACTPHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.